Skip to main content
Log in

Transient lupus anticoagulant associated with hypoprothrombinemia and Factor XII deficiency following adenovirus infection

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Summary

A potent lupus anticoagulant (LA) was detected in four children, 1 week after the clinical onset of an adenovirus infection. The adenovirus infection was documented by direct virus detection in the stool of one patient and serologically in the others. None of the children had elevated titers of IgM- and only one of IgG-anticardiolipin antibodies (ACA). All patients had a marked reduction of prothrombin activity as well as antigen. Prothrombin-antibody complexes were demonstrated in the patients' plasma or mixtures of patient and normal plasma. Factor XII activity was moderately reduced in three of the patients. All coagulation abnormalities returned to normal within 4–12 weeks. Localized bleeding was observed in two cases, but there was no generalized bleeding tendency or evidence of thrombosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bajaj SP, Rapaport SI, Fierer DS, Herbst KD, Schwartz DB (1983) A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood 61:684–692

    PubMed  Google Scholar 

  2. Beck DW, Strauss RG, Kisker T, Henriksen RA (1979) An intrinsic coagulation pathway inhibitor in a 3-year-old child. Am J Clin Pathol 71:470

    PubMed  Google Scholar 

  3. Boxer M, Ellman L, Carvalho A (1976) The lupus anticoagulant. Arthritis Rheum 19:1244–1248

    PubMed  Google Scholar 

  4. Brodeur GM, O'Neill PJ, Williams JA (1980) Acquired inhibitors of coagulation in nonhemophilic children. J Pediatr 96:439

    PubMed  Google Scholar 

  5. Colaco CB, Mackie IL, Irving W, Machin SJ (1989) Anti-cardiolipin antibodies in viral infection. Lancet 18:622

    Google Scholar 

  6. Edson JR, Vogt JM, Hasegawa DK (1984) Anbnormal prothrombin crossed-immunoelectrohoresis in patients with lupus inhibitors. Blood 64:807–816

    PubMed  Google Scholar 

  7. Feinstein DI (1991) Acquired inhibitors of blood coagulation. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ (eds) Hematology-basic principles and practice, 1st edn. Churchill Livingstone, New York, pp 1385–1394

    Google Scholar 

  8. Fleck RA, Rapaport SI, Rao LVM (1988) Anti-prothrombin antibodies and the lupus anticoagulant. Blood 72:512–519

    PubMed  Google Scholar 

  9. Kapiotis S, Speiser W, Pabinger-Fasching I, Kyrle PA, Lechner K (1991) Anticardiolipin antibodies in patients with venous thrombosis. Haemostasis 21:19–24

    PubMed  Google Scholar 

  10. Lechner K (1969) A new type of coagulation inhibitor. Thromb Diath Haemorrh 21:442–449

    Google Scholar 

  11. Lechner K (1974) Acquired inhibitors in non-hemophilic patients. Haemostasis 3:65–93

    PubMed  Google Scholar 

  12. Lechner K, Pabinger-Fasching I (1985) Lupus anticoagulants and thrombosis. Haemostasis 15:254–262

    PubMed  Google Scholar 

  13. Pabinger-Fasching I, Bertina RM, Lechner K, Niessner H, Korninger C (1983) Protein C deficiency in two Austrian families. Thromb Haemost 50:810–813

    PubMed  Google Scholar 

  14. Rauch J, Tannenbaum M, Janoff AS (1989) Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids. Thromb Haemost 62:892–896

    PubMed  Google Scholar 

  15. Roisin JP, Contant G, Martinoli JL (1991) Detection of lupus-like anticoagulants (LA). Use of hexagonal phosphatidylethanolamine and of an APTT reagent sensitive to LA. Throm Haemost 65:1255

    Google Scholar 

  16. Rugman FP, Pinn G, Palmer MF, Waite M, Hay CR (1991) Anticardiolipin antibodies in leptospirosis. J Clin Patheol 44:517–519

    Google Scholar 

  17. Schleider MA, Nachman RL, Jaffe EA, Colaman M (1976) A clinical study of the lupus anticoagulant. Blood 48:499–509

    PubMed  Google Scholar 

  18. Thiagarajan P, Shapiro SS, De Marco L (1980) Monoclonal immunoglobulin M-gamma coagulation inhibitor with phospholipid specificity: mechanism of a lupus anticoagulant. J Clin Invest 66:397–405

    PubMed  Google Scholar 

  19. Triplett DA, Brandt JT, Musgrave KA, Orr CA (1988) The relationship between lupus anticoagulants and antibodies to phospholipid. JAMA 259:550–554

    PubMed  Google Scholar 

  20. Wright PF (1992) Adenoviruses. In: Kelly WN (ed) Textbook of internal medicine, 2nd edn. Lippincott, Philadelphia, p 1481

    Google Scholar 

  21. Yamazaki M, Asakura H, Kawamura Y, Ohka T, Endo M, Matsuda T (1991) Transient lupus anticoagulant induced by Epstein-Barr virus infection. Blood Coagul Fibrinolysis 2:771–774

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jaeger, U., Kapiotis, S., Pabinger, I. et al. Transient lupus anticoagulant associated with hypoprothrombinemia and Factor XII deficiency following adenovirus infection. Ann Hematol 67, 95–99 (1993). https://doi.org/10.1007/BF01788133

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01788133

Key words

Navigation